MoneyWorks4Me

Shelter Pharma informs about completion and commencement of dispatch of export order

24 Aug 2026 Evaluate
Pursuant to Regulation 30 read with schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shelter Pharma has informed that the Company has successfully completed the manufacturing of the export purchase order received from Taha Drugs & Chemicals Co for the supply of Joemega Capsule aggregating 1,44,000 $. They further informed that the aforesaid amount has been fully settled and the said order has been dispatched to Sudan. The Management of Shelter Pharma has informed that the export order to Sudan has been successfully completed and delivered, thus setting yet another milestone in the growth journey of the Company. This success highlights the growing international presence of the Company along with its dedication towards prompt delivery of high-quality products to its customers around the globe. This success is a clear reflection of the modern manufacturing facility, stringent quality control systems and hard work of the team of experts at the Company. The success of the order once again highlights the commitment of the Company towards ethical business practices as well as the trust reposed in the Company by international stakeholders. As a growing name in the field of Pharmaceutical and Nutraceuticals, the Company continues to be committed towards innovation and quality in all its products. 

The above information is a part of company’s filings submitted to BSE.

Shelter Pharma Share Price

31.60 0.23 (0.73%)
04-Sep-2026 15:01 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1900.70
Dr. Reddys Labs. 1155.90
Cipla 1378.00
Lupin 2104.55
Zydus Lifesciences 1125.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: